May 1, 2025EventRedTailTransforming all Tumor Sites: The Power of Systemic Enveloped VirotherapySITC 2024
June 24, 2024EventRedTailTransforming Tumor Immune Microenvironments with a Novel Systemic Enveloped Oncolytic Virotherapy Targeting All Tumor SitesASCO Annual Meeting 2024
June 1, 2024EventSuperNovaNon-Clinical Evidence Supporting the Upcoming CLD-201 Clinical Trial: Cell-Based Oncolytic Virotherapy for Multiple Solid TumorsASCO Annual Meeting 2024
April 16, 2024EventSuperNova & NeuroNovaStem Cell Platforms for Enhanced Oncolytic VirotherapyFestival of Biologics
April 9, 2024EventSuperNova & NeuroNovaDeciphering Anticancer Mechanisms of Oncolytic Virus-loaded Stem CellsAmerican Association for Cancer Research
November 23, 2023EventSuperNovaAnnual Meeting – SITC 2023 – Nov 1st to 5th 2023 in San Diego, CA, USA.SUPERNOVA1 (SNV1), A NOVEL ONCOLYTIC-CELL BASED PLATFORM FOR CANCER THERAPY
November 7, 2018EventNeuroNovaThe Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting | November 7-11, 2018 Washington, D.C.Abstract P617: A cell-based platform to protect and enhance oncolytic virus therapies
November 7, 2018EventNeuroNovaThe Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting | November 7-11, 2018 Washington, D.C.Abstract P609: First in man study of TK positive oncolytic vaccinia virus delivered by adipose…
